How Drug Brands Stopped Off-Label Use and Stayed on the Market
How drug brands fought off-label prescribing to survive: real FDA cases, litigation wins, and what AI monitoring means for pharmacovigilance […]
How drug brands fought off-label prescribing to survive: real FDA cases, litigation wins, and what AI monitoring means for pharmacovigilance […]
Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s
Inside the wonderfully unfiltered world of drug questions people actually ask online Spend enough time around pharmaceutical R&D and you
Pfizer paid $2.3 billion in 2009. GlaxoSmithKline paid $3 billion in 2012. AstraZeneca paid $520 million in 2010. Each of
On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24
There’s a repeating theme across DrugChatter: not “what are the side effects?” but “is this normal—or something I should worry
There’s a quiet sorting mechanism in medicine that has little to do with pharmacology textbooks and everything to do with
If you spend enough time around athletes, weekend warriors, or anyone optimizing “fitness,” you start to notice a recurring theme:
Every so often the public conversation about medicines drifts into a familiar question: why is this one so expensive? But
Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The
AI Agents Now Influence Which Drugs Patients Ask For — Here’s the Pharma Playbook When a patient with newly diagnosed
AI Pharmacovigilance: How Drug Companies Track Safety Signals Before Regulators Do The FDA receives roughly 2 million adverse event reports